LINCOPH.BO
Price:
$638.15
Market Cap:
$12.76B
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative, as well as dermatologist preparations, gynecological products, gastrointestinal rang, otology products, and phosphodiesterase type 5 inhi...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-07-01
Stock Exchange
BSE
Ticker
LINCOPH.BO
According to Lincoln Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is 23.62. This represents a change of 109.56% compared to the average of 11.27 of the last 4 quarters.
The mean historical PE Ratio of Lincoln Pharmaceuticals Limited over the last ten years is 7.91. The current 23.62 PE Ratio has changed 29.74% with respect to the historical average. Over the past ten years (40 quarters), LINCOPH.BO's PE Ratio was at its highest in in the March 2023 quarter at 13.50. The PE Ratio was at its lowest in in the September 2022 quarter at 6.01.
Average
7.91
Median
8.85
Minimum
5.20
Maximum
9.31
Discovering the peaks and valleys of Lincoln Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 38.98%
Maximum Annual PE Ratio = 9.31
Minimum Annual Increase = -41.22%
Minimum Annual PE Ratio = 5.20
Year | PE Ratio | Change |
---|---|---|
2023 | 9.31 | 3.60% |
2022 | 8.98 | 24.25% |
2021 | 7.23 | 38.98% |
2020 | 5.20 | -41.22% |
The current PE Ratio of Lincoln Pharmaceuticals Limited (LINCOPH.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
8.51
5-year avg
7.91
10-year avg
7.91
Lincoln Pharmaceuticals Limited’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lincoln Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lincoln Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Lincoln Pharmaceuticals Limited's PE Ratio?
How is the PE Ratio calculated for Lincoln Pharmaceuticals Limited (LINCOPH.BO)?
What is the highest PE Ratio for Lincoln Pharmaceuticals Limited (LINCOPH.BO)?
What is the 3-year average PE Ratio for Lincoln Pharmaceuticals Limited (LINCOPH.BO)?
What is the 5-year average PE Ratio for Lincoln Pharmaceuticals Limited (LINCOPH.BO)?
How does the current PE Ratio for Lincoln Pharmaceuticals Limited (LINCOPH.BO) compare to its historical average?